Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management.

Autor: Tetart F; Department of Dermatology and Allergology, Charles Nicolle University Hospital, Rouen, France.; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France., Walsh S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, King's College Hospital, London, UK., Milpied B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Gaspar K; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Vorobyev A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.; Department of Dermatology, University Medical Center Schleswig-Holstein, Lübeck, Germany., Tiplica GS; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology II, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Didona B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Center of Rare Diseases IDI-IRCCS-Rome, Rome, Italy., Welfringer-Morin A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Necker-Enfants Malades University Hospital, Paris, France., Kucinskiene V; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno Klinikos, Kaunas, Lithuania., Bensaid B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, Edouard Herriot University Hospital, Lyon, France., Marvanova E; Department of Dermatovenereology, Faculty of Medicine, St. Ann's University Hospital, Masaryk University, Brno, Czech Republic., Salavastru C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Paediatric Dermatology, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Brezinova E; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatovenereology, Faculty of Medicine, St. Ann's University Hospital, Masaryk University, Brno, Czech Republic., Chua SL; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, University Hospitals Birmingham, Birmingham, UK., Lovgren ML; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Birmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Hammers CM; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Christian-Albrechts-University Kiel, Kiel, Germany., Barbaud A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology and Allergology, Tenon Hospital, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Paris, France., Mortz CG; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Horvath B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Center for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Meyersburg D; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University Salzburg, Salzburg, Austria., Lebrun-Vignes B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France., Bodemer C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, Necker-Enfants Malades University Hospital, Paris, France., Brüggen MC; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Christine Kühne-Center for Allergy Research and Education Davos (CK-CARE), Davos, Switzerland., French LE; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.; Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA., Ingen-Housz-Oro S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, AP-HP, Henri Mondor University Hospital, Créteil, France.; Univ Paris Est Créteil EpiDermE, Créteil, France.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Nov; Vol. 38 (11), pp. 2073-2081. Date of Electronic Publication: 2024 Jul 18.

Clinical characteristics, treatment and outcome of clindamycin induced acute generalized exanthematous pustulosis.

Autor: Wu Z; College of Pharmacy, Changsha Medical University, Changsha, 410219, Hunan, China.; Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, 410219, Hunan, China., Sun W; Department of Pharmacy, The Third Xiangya Hospital, Central South University, No. 138 Tongzipo Road, YueLu District, Changsha, 410013, Hunan, China., Wang C; College of Pharmacy, Changsha Medical University, Changsha, 410219, Hunan, China. wongcj@csu.edu.cn.; Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, 410219, Hunan, China. wongcj@csu.edu.cn.

Publikováno v: Archives of dermatological research [Arch Dermatol Res] 2024 Aug 24; Vol. 316 (8), pp. 573. Date of Electronic Publication: 2024 Aug 24.

Acute generalized exanthematous pustulosis: Analysis of cases managed in a Tunisian tertiary hospital.

Autor: Fathallah N; Faculty of Medicine of Sousse, Department of Pharmacology, University of Sousse, 4000 Sousse, Tunisia. Electronic address: neilafathallah@gmail.com., Kenani Z; Department of Dermatology, Farhat Hached University Hospital, 4000 Sousse, Tunisia., Mokni S; Department of Dermatology, Farhat Hached University Hospital, 4000 Sousse, Tunisia., Gammoudi R; Department of Dermatology, Farhat Hached University Hospital, 4000 Sousse, Tunisia., Slim R; Faculty of Medicine of Sousse, Department of Pharmacology, University of Sousse, 4000 Sousse, Tunisia., Fetoui Ghariani N; Department of Dermatology, Farhat Hached University Hospital, 4000 Sousse, Tunisia., Ghariani N; Department of Dermatology, Farhat Hached University Hospital, 4000 Sousse, Tunisia., Ben Salem C; Faculty of Medicine of Sousse, Department of Pharmacology, University of Sousse, 4000 Sousse, Tunisia., Ouni B; Faculty of Medicine of Sousse, Department of Pharmacology, University of Sousse, 4000 Sousse, Tunisia., Denguezli M; Department of Dermatology, Farhat Hached University Hospital, 4000 Sousse, Tunisia.

Publikováno v: Therapie [Therapie] 2024 Jul-Aug; Vol. 79 (4), pp. 469-474. Date of Electronic Publication: 2023 Dec 14.

Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab.

Autor: Xuan Y; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China., Jin S; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China., Zhang C; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China., Wang S; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.

Publikováno v: JAMA dermatology [JAMA Dermatol] 2024 Sep 01; Vol. 160 (9), pp. 1009-1012.

Acute generalised exanthematous pustulosis and herpes simplex virus: a case of possible overlap.

Autor: Zachian RL; Internal Medicine, Lankenau Medical Center, Wynnewood, Pennsylvania, USA rzachian@gmail.com.; Dermatology, University of Maryland, Baltimore, Maryland, USA., Sidhu BV; Internal Medicine, Lankenau Medical Center, Wynnewood, Pennsylvania, USA., Liu P; Internal Medicine, Lankenau Medical Center, Wynnewood, Pennsylvania, USA., Weimann R; Main Line Health System, King of Prussia, Pennsylvania, USA.; Schweiger Dermatology Group, King of Prussia, Pennsylvania, USA.

Publikováno v: BMJ case reports [BMJ Case Rep] 2024 Aug 30; Vol. 17 (8). Date of Electronic Publication: 2024 Aug 30.